- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07888777
Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing Hemodialysis
The Effect of Manual Acupuncture on Intradialytic Nausea and Vomiting Scores in Patients With Chronic Kidney Disease Undergoing Routine Hemodialysis: A Randomized Controlled Trial
This study aims to evaluate the immediate effects of acupuncture therapy at three specific acupuncture points (PC6, ST36, and KI3) on intradialysis nausea and vomiting in patients with chronic kidney disease undergoing regular hemodialysis. The outcome will be assessed using the Rhodes Index of Nausea, Vomiting, and Retching (RINVR) score one hour during the treatment and two hours after completion of hemodialysis.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anthonius S Rulie, MD
- Phone Number: +6285942085155
- Email: anthoniusrulie@gmail.com
Study Locations
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Universitas Indonesia
-
Contact:
- Anthonius S Rulie, MD
- Phone Number: +6285942085155
- Email: anthoniusrulie@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with chronic kidney disease (CKD) who experience intradialytic nausea and vomiting, undergo routine hemodialysis twice weekly for at least 6 months, and are hemodynamically stable.
- Subjects aged 18-59 years.
- Subjects who have not received acupuncture therapy within at least one month prior to the study.
- Subjects who are willing to participate in the study according to the scheduled protocol until completion and who have signed the informed consent form.
Exclusion Criteria:
- Subjects with malignancies or infected wounds at the acupuncture point sites intended for intervention.
- Subjects with primary skin diseases, such as allergic dermatitis, irritant contact dermatitis, neurodermatitis, and psoriasis.
- Subjects with a history of hypersensitivity reactions to previous acupuncture therapy, including stainless steel allergy, atopy, keloid formation, or other hypersensitivity reactions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Manual Acupuncture
Manual acupuncture is performed at bilateral PC6 (Neiguan), ST36 (Zusanli), and KI3 (Taixi) using sterile Huanqiu® needles (0.25 × 25 mm) inserted 20 mm deep through a hole in a transparent waterproof Onemed® plaster, guided by a 20-mm tube. Needles are retained for 20 minutes without manipulation and then removed, twice per treatment period. Sample are blindfolded during the procedure. Device: Manual Acupuncture The manual acupuncture is using sterile Huanqiu® needles |
The manual acupuncture is using sterile Huanqiu® needles |
|
Sham Comparator: Sham Acupuncture
Manual acupuncture is performed at bilateral PC6 (Neiguan), ST36 (Zusanli), and KI3 (Taixi) using with blunt-tipped needles that only press against an intact plaster without penetrating the skin above the Onemed® plaster, pressed by a 20-mm tube, controlling for pressure sensation and expectation. Sample are blindfolded during the procedure. Device: Sham Acupuncture The sham acupuncture using blunt-tipped needles |
The sham acupuncture using blunt-tipped needles |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rhodes Index of Nausea, Vomiting and Retching (RINVR)
Time Frame: baseline (after dialysis is running for 1 hour), 2 hours after dialysis is finished
|
baseline (after dialysis is running for 1 hour), 2 hours after dialysis is finished
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Medical Acupuncture Study Program FKUI, Medical Acupuncture Study Program Faculty of Medicine Universitas Indonesia
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Pathologic Processes
- Male Urogenital Diseases
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Chronic Disease
- Disease Attributes
- Signs and Symptoms, Digestive
- Renal Insufficiency
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Vomiting
- Renal Insufficiency, Chronic
- Therapeutics
- Complementary Therapies
- Acupuncture Therapy
Other Study ID Numbers
- 0328/EC/KEPK/09/2026_
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.